244 related articles for article (PubMed ID: 31859163)
21. Self-managed abortion: a constellation of actors, a cacophony of laws?
Berro Pizzarossa L; Nandagiri R
Sex Reprod Health Matters; 2021 Dec; 29(1):1899764. PubMed ID: 33764856
[No Abstract] [Full Text] [Related]
22. Self-managed Medication Abortion in the United States.
Jung C; Nippita S
Clin Obstet Gynecol; 2023 Dec; 66(4):739-748. PubMed ID: 37750672
[TBL] [Abstract][Full Text] [Related]
23. U.S. Abortion Care Providers' Perspectives on Self-Managed Abortion.
Baldwin A; Johnson DM; Broussard K; Tello-Pérez LA; Madera M; Ze-Noah C; Padron E; Aiken ARA
Qual Health Res; 2022 Apr; 32(5):788-799. PubMed ID: 35322703
[TBL] [Abstract][Full Text] [Related]
24. Cervical preparation for first trimester surgical abortion.
Kapp N; Lohr PA; Ngo TD; Hayes JL
Cochrane Database Syst Rev; 2010 Feb; (2):CD007207. PubMed ID: 20166091
[TBL] [Abstract][Full Text] [Related]
25. Providing Abortion Services in the Primary Care Setting.
Amico JR; Cheng TL; Godfrey EM
Prim Care; 2018 Dec; 45(4):599-613. PubMed ID: 30401344
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.
Creinin MD; Vittinghoff E; Keder L; Darney PD; Tiller G
Contraception; 1996 Jun; 53(6):321-7. PubMed ID: 8773418
[TBL] [Abstract][Full Text] [Related]
27. Roots, Leaves, and Flowers: A Narrative Review of Herbs and Botanicals Used for Self-Managed Abortion in Asia and the Pacific.
Chen TX; Hamachi A; Soon R; Natavio M
J Midwifery Womens Health; 2023; 68(6):710-718. PubMed ID: 37668006
[TBL] [Abstract][Full Text] [Related]
28. Misoprostol for women's health: a review.
Blanchard K; Clark S; Winikoff B; Gaines G; Kabani G; Shannon C
Obstet Gynecol; 2002 Feb; 99(2):316-32. PubMed ID: 11814515
[TBL] [Abstract][Full Text] [Related]
29. Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis.
Wu HL; Marwah S; Wang P; Wang QM; Chen XW
Sci Rep; 2017 May; 7(1):1664. PubMed ID: 28490770
[TBL] [Abstract][Full Text] [Related]
30. Women's reasons for choosing abortion method: A systematic literature review.
Kanstrup C; Mäkelä M; Hauskov Graungaard A
Scand J Public Health; 2018 Dec; 46(8):835-845. PubMed ID: 28691571
[TBL] [Abstract][Full Text] [Related]
31. Building Bridges: A Case for Community Health Worker Provision of Misoprostol-Only Abortion in the First Trimester.
Tebbets C; Santana D; Ros Silvestre J; Redwine D
J Womens Health (Larchmt); 2018 Mar; 27(3):311-316. PubMed ID: 29040004
[TBL] [Abstract][Full Text] [Related]
32. Safe abortion information hotlines: An effective strategy for increasing women's access to safe abortions in Latin America.
Drovetta RI
Reprod Health Matters; 2015 May; 23(45):47-57. PubMed ID: 26278832
[TBL] [Abstract][Full Text] [Related]
33. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
[TBL] [Abstract][Full Text] [Related]
34. Ethics challenges and guidance related to research involving adolescent post-abortion care: a scoping review.
Zulu JM; Ali J; Hallez K; Kass N; Michelo C; Hyder AA
Reprod Health; 2018 May; 15(1):71. PubMed ID: 29720276
[TBL] [Abstract][Full Text] [Related]
35. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
36. A qualitative exploration of how the COVID-19 pandemic shaped experiences of self-managed medication abortion with accompaniment group support in Argentina, Indonesia, Nigeria, and Venezuela.
Bercu C; Filippa S; Jayaweera R; Egwuatu I; Nmezi S; Zurbriggen R; Grosso B; Kristianingrum IA; Maneiro M; Liparelli MS; Sandoval S; Tapia I; Soria G; Moseson H
Sex Reprod Health Matters; 2022 Dec; 30(1):2079808. PubMed ID: 35713531
[TBL] [Abstract][Full Text] [Related]
37. Perceptions of misoprostol among providers and women seeking post-abortion care in Zimbabwe.
Maternowska MC; Mashu A; Moyo P; Withers M; Chipato T
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):16-25. PubMed ID: 25702065
[TBL] [Abstract][Full Text] [Related]
38. [Medical induced abortion].
Bettahar K; Pinton A; Boisramé T; Cavillon V; Wylomanski S; Nisand I; Hassoun D
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1490-1514. PubMed ID: 27818118
[TBL] [Abstract][Full Text] [Related]
39. Current medical abortion care.
Creinin MD
Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
[TBL] [Abstract][Full Text] [Related]
40. Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
Chen MJ; Creinin MD
Obstet Gynecol; 2015 Jul; 126(1):12-21. PubMed ID: 26241251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
